NCT00533481View on ClinicalTrials.gov

Efficacy of MK0557 in Combination With Sibutramine or Orlistat (0557-015)(COMPLETED)

PHASE2CompletedINTERVENTIONAL

Enrollment

497

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

December 31, 2004

Study Completion Date

December 31, 2004

Conditions

Obesity

Interventions

DRUG

MK0557

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00533481 - Efficacy of MK0557 in Combination With Sibutramine or Orlistat (0557-015)(COMPLETED) | Biotech Hunter | Biotech Hunter